Recorded fact · drug.label_indication
drug.label_indication for sotorasib|colorectal-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact e026a3ac resolves to.
The record
| Fact id | e026a3ac2e5ef353e30bd4e2 |
|---|---|
| Entity | drug: sotorasib|colorectal-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250122 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
KRAS G12C-mutated Metastatic Colorectal Cancer (mCRC) In combination with panitumumab, for the treatment of adult patients with KRAS G12C-mutated mCRC as determined by an FDA approved-test, who have received prior fluoropyrimidin
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 5c96ee7aaef7db1e73ef83321941baf3cd0fb21fd000c2edcfeccd3e3b5940dd.
The value
{
"ingredient": "Sotorasib",
"conditionId": "colorectal-cancer",
"conditionName": "Colorectal cancer",
"matchedAlias": "Colorectal Cancer",
"context": "indication",
"brand": "LUMAKRAS",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "c80a362c-7ac3-4894-a076-0691e68ef8c1",
"labelEffectiveTime": "20250122",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 832bc79841eacca5617c0d6f188f8cfd6a687b3d110b5e04b382efe2806a6b0b.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.